BlackRock Investment Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$628K Sell
147,850
-6,168
-4% -$20.3K ﹤0.01% 2955
2016
Q3
$411K Sell
154,018
-135
-0.1% -$310 ﹤0.01% 3106
2016
Q2
$273K Buy
154,153
+14,865
+11% +$30.3K ﹤0.01% 3243
2016
Q1
$323K Buy
139,288
+2,064
+2% +$4.67K ﹤0.01% 3058
2015
Q4
$476K Buy
137,224
+237
+0.2% +$1.14K ﹤0.01% 3023
2015
Q3
$840K Buy
136,987
+3,801
+3% +$25.8K ﹤0.01% 2722
2015
Q2
$879K Buy
133,186
+60,651
+84% +$409K ﹤0.01% 2867
2015
Q1
$516K Buy
+72,535
New +$547K ﹤0.01% 2948

Other funds holding GEN

BlackRock Investment Management's GEN Position: Q4 2016 in Review

BlackRock Investment Management reduced its Genesis Healthcare, Inc. (GEN) stake by 4% in Q4 2016, selling an estimated $20.3K and leaving 147,850 shares worth $628K. The position accounts for ﹤0.01% of the portfolio, ranked #2955.

BlackRock Investment Management first reported a position in GEN in Q1 2015 and has held it in 8 quarters since. The position peaked at $879K in Q2 2015. 77 funds tracked by Wall St. Rank hold GEN as of Q4 2016.

  • BlackRock Investment Management held 147,850 shares of Genesis Healthcare, Inc. worth $628K as of Q4 2016.
  • BlackRock Investment Management sold 6,168 Genesis Healthcare, Inc. shares in Q4 2016, an estimated $20.3K.
  • Genesis Healthcare, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2955 holding.
  • BlackRock Investment Management first reported a position in Genesis Healthcare, Inc. in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Investment Management's Genesis Healthcare, Inc. position peaked at $879K in Q2 2015.
  • 77 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.